Guidance on the emergent reversal of oral thrombin and factor Xa inhibitorsScott Kaatz, Jack Ansell, Anthony K.C. Chan et al.|American Journal of Hematology|2012Cited by 366
Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acidPeter A. Kouides, Roshni Kulkarni, Vanessa R. Byams et al.|British Journal of Haematology|2009Cited by 140
Emerging clinical concerns in the ageing haemophilia patientBarbara A. Konkle, Bruce M. Ewenstein, Craig M. Kessler et al.|Haemophilia|2009Cited by 68
Standardization of definition and management for bleeding disorder of unknown cause: communication from the SSC of the ISTHRoss Baker, James S. O’Donnell, Nicola Curry et al.|Journal of Thrombosis and Haemostasis|2024Cited by 51
The use of a single von Willebrand factor‐containing, plasma‐derived FVIII product in hemophilia A immune tolerance induction: the US experienceMargaret Kurth, Louis M. Aledort, Ellis J. Neufeld et al.|Journal of Thrombosis and Haemostasis|2011Cited by 46